These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 3282887)
21. [Hibernating myocardium and the 'no reflow' phenomenon: a study of absolute regional myocardial perfusion and glucose metabolism using positron emission tomography in chronic and acute heart disorders]. Maes A; Nuyts J Verh K Acad Geneeskd Belg; 1997; 59(3):133-60. PubMed ID: 9490915 [TBL] [Abstract][Full Text] [Related]
23. 18F-deoxyglucose and the assessment of myocardial viability. Schelbert HR Semin Nucl Med; 2002 Jan; 32(1):60-9. PubMed ID: 11839071 [TBL] [Abstract][Full Text] [Related]
24. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. de Silva R; Yamamoto Y; Rhodes CG; Iida H; Nihoyannopoulos P; Davies GJ; Lammertsma AA; Jones T; Maseri A Circulation; 1992 Dec; 86(6):1738-42. PubMed ID: 1451245 [TBL] [Abstract][Full Text] [Related]
25. [Imaging of myocardial perfusion and metabolism with positron emission tomography]. Ishida Y; Fukuchi K; Oka M; Sagoh M; Miyake Y; Hasimoto N Nihon Rinsho; 1998 Mar; 56(3):813-23. PubMed ID: 9549377 [TBL] [Abstract][Full Text] [Related]
26. Use and limitations of metabolic tracers labeled with positron-emitting radionuclides in the identification of viable myocardium. Bergmann SR J Nucl Med; 1994 Apr; 35(4 Suppl):15S-22S. PubMed ID: 8151408 [TBL] [Abstract][Full Text] [Related]
28. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium. Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297 [TBL] [Abstract][Full Text] [Related]
29. Time dependence of residual tissue viability after myocardial infarction assessed by [18F]fluorodeoxyglucose and positron emission tomography. Fragasso G; Chierchia SL; Lucignani G; Landoni C; Conversano A; Gilardi MC; Colombo F; Rossetti C; Fazio F Am J Cardiol; 1993 Dec; 72(19):131G-139G. PubMed ID: 8279350 [TBL] [Abstract][Full Text] [Related]
30. Comparison of thallium scintigraphy and positron emission tomography. Niemeyer MG; Kuijper AF; Meeder JG; Cramer MJ; Cleophas AJ; van der Wall EE Angiology; 1997 Oct; 48(10):843-53. PubMed ID: 9342963 [TBL] [Abstract][Full Text] [Related]
31. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Lucignani G; Paolini G; Landoni C; Zuccari M; Paganelli G; Galli L; Di Credico G; Vanoli G; Rossetti C; Mariani MA Eur J Nucl Med; 1992; 19(10):874-81. PubMed ID: 1451704 [TBL] [Abstract][Full Text] [Related]
32. Assessment of myocardial perfusion by positron emission tomography. Schwaiger M; Muzik O Am J Cardiol; 1991 May; 67(14):35D-43D. PubMed ID: 2035433 [TBL] [Abstract][Full Text] [Related]
33. [Clinical indications for PET of the heart]. von Schulthess GK; Schwaiger M Schweiz Rundsch Med Prax; 1993 Aug; 82(34):914-8. PubMed ID: 8372296 [TBL] [Abstract][Full Text] [Related]
34. The role of PET with 13N-ammonia and 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection. Castellani M; Colombo A; Giordano R; Pusineri E; Canzi C; Longari V; Piccaluga E; Palatresi S; Dellavedova L; Soligo D; Rebulla P; Gerundini P J Nucl Med; 2010 Dec; 51(12):1908-16. PubMed ID: 21078804 [TBL] [Abstract][Full Text] [Related]
35. Cardiac positron emission tomography. Geltman EM West J Med; 1985 Dec; 143(6):764-72. PubMed ID: 3879048 [TBL] [Abstract][Full Text] [Related]
36. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate. Visser FC Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301 [TBL] [Abstract][Full Text] [Related]
37. 13N-ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization. Kitsiou AN; Bacharach SL; Bartlett ML; Srinivasan G; Summers RM; Quyyumi AA; Dilsizian V J Am Coll Cardiol; 1999 Mar; 33(3):678-86. PubMed ID: 10080468 [TBL] [Abstract][Full Text] [Related]
38. Regional myocardial perfusion and metabolism assessed by positron emission tomography in children with Kawasaki disease and significance of abnormal Q waves and their disappearance. Yoshibayashi M; Tamaki N; Nishioka K; Matsumura M; Ueda T; Temma S; Yonekura Y; Yamashita K; Konishi J; Mikawa H Am J Cardiol; 1991 Dec; 68(17):1638-45. PubMed ID: 1746466 [TBL] [Abstract][Full Text] [Related]
39. Recovery of perfusion, glucose utilization and fatty acid utilization in stunned myocardium. Tsubokawa A; Lee JD; Shimizu H; Nakano A; Uzui H; Takeuchi M; Tsuchida T; Yonekura Y; Ishii Y; Ueda T J Nucl Med; 1997 Dec; 38(12):1835-7. PubMed ID: 9430454 [TBL] [Abstract][Full Text] [Related]